Trial Site Detail
Drug: |
Bezuclastinib plus Sunitinib |
|||
|---|---|---|---|---|
Trial: |
(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Recruiting |
|||
University of Toledo Medical Center |
Principal Investigator: |
Roland Skeel |
|---|---|
Contact: |
419-383-6967 peakinfo@cogentbio.com |
Activation Status of this Site: |
Active |
Notes about this Site: |
|
University of Toledo Medical Center Website: |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.